Printable Handouts

PDF

Navigable Slide Index

1. Introduction
2. Talk overview
3. Pneumococcal serotype
4. Capsule biosynthesis genes
5. Capsule antigenicity
6. Global serotype distribution of IPD in children (1)
7. Global serotype distribution of IPD in children (2)
8. Serotype distribution: age, syndrome or body fluid
9. Regional serotype distribution
10. Regional prevalence of serotypes
11. Regional serotype distribution by age
12. Serotype-specific disease and mortality
13. Serotype associated mortality
14. Serotype-specific incidence by region
15. Serotype-specific mortality by region
16. Epidemiology – pre-vaccine
17. Pneumococcal vaccines
18. Epidemiology – post-vaccine
19. IPD and HIV-positive epidemiology
20. How serotypes differ between carriage and IPD
21. Detailed nasopharyngeal ecology
22. Evolution during carriage
23. Geographic distribution of QS pherotypes
24. Multiple pherotypes co-colonizing the nasopharynx
25. Conclusions

Topics Covered

• Pneumococcal serotype
• Capsule biosynthesis genes and antigenicity
• Global serotype distribution of IPD in children
• Serotype distribution: age, syndrome or body fluid
• Regional serotype distribution & prevalence
• Serotype-specific disease incidence & mortality by region
• Epidemiology (pre- and post-vaccine)
• Pneumococcal vaccines
• IPD and HIV-positive epidemiology
• How serotypes differ between carriage and IPD
• Detailed nasopharyngeal ecology
• Evolution during carriage
• Geographic distribution of QS pherotypes
• Multiple pherotypes co-colonizing the nasopharynx

Links

Series:

• Respiratory Infection

Categories:

• Immunology
• Microbiology

Therapeutic Areas:

• Infectious Diseases
• Respiratory Diseases

Talk Citation

Charalambous, B. (2013, July 11). Streptococcus pneumoniae: serotype diversity and epidemiology [Video file]. In The Biomedical & Life Sciences Collection, Henry Stewart Talks. Retrieved November 21, 2024, from https://doi.org/10.69645/VQHG8695.
Export Citation (RIS)

Publication History

• Published on July 11, 2013

Financial Disclosures

• Dr. Bambos Charalambous has not informed HSTalks of any commercial/financial relationship that it is appropriate to disclose.